Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
Is OSAS a systemic disease? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007
A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013
Is classical OSA the same as OSA in other diseases ? Source: 5th Sleep and Breathing Conference Year: 2019
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007
OSAS and the incidence of cardiovascular disorders Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Sleep disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Sleep-related breathing disorders: impact on mortality of cerebrovascular disease Source: Eur Respir J 2004; 24: 267-272 Year: 2004
Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Sleep in chronic respiratory disease: COPD and hypoventilation disorders Source: Eur Respir Rev, 28 (153) 190064; 10.1183/16000617.0064-2019 Year: 2019
Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018
Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006
The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020